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response episode to compare would denote that the vessel in
volunteer 1 dilated more or less than that in volunteer 2. Which
flicker episode should therefore be chosen for comparison?
Smokers in the study by Heitmar et al.1 demonstrated signifi-
cant differences from the control group in the first flicker
episode. Such variation may not be the case for other diseases.
Using this approach on another group of healthy volunteers
may demonstrate different results, despite their similar patho-
physiologic status.
Finally, the reference to a single temporal time point and a
single flicker episode included in the parameter D is too
uncertain from the standpoint of the RVA measurement tech-
nique,2,5 since a qualitative assessment of each single flicker
episode is not always possible in all subjects (e.g., elderly
persons, subjects with bad fixation, or those who blink during
the assessment), which represent a serious limitation of the
method presented by Heitmar et al.1
Therefore, our main criticism of Heitmar et al. relates to
each of the two suggested indices of the SDRA method. Their
supposed index APR describing vascular elasticity is arbitrary.
It does not convey any information regarding vascular elastic-
ity, and its values are not reported in the paper. Their other
index, D, does not add any new information for an individual
subject, since its definition is arbitrary. Regarding this second
index, Heitmar et al.1 discuss two additional points that super-
sede the standard vessel dilation assessment:
1. Their method supports the necessity of assessing the
maximum dilation at the time point of its occurrence
rather than at the fixed time point of flicker cessation.
This aspect has been described and discussed else-
where.3,6
2. It shows a possible higher rate of dilation in the first
flicker episode in the group of healthy subjects, com-
pared with subsequent episodes, and in the first flicker
episode in smokers. In a healthy population, this effect
has been described in other publications.2,3 Since dila-
tion depends on the baseline state, which is not always
the same in all the flicker episodes, the value of this
finding is debatable.
We would like to point out that it is worthwhile to interpret
vessel diameter changes and their dynamics, which include
superimposed systemic and local effects caused by cardiac
pulsations, breathing rhythms, blood pressure waves and vaso-
motion, among others,2,4,7 and result in a different measured
diameter at any given time point. Heitmar et al.1 acknowledge
this fact and integrate it into their calculations by using BDF,
which we think may be an important parameter to consider for
the assessment of vascular health in the future.
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Author Response: Can Vascular Function Be
Assessed by the Interpretation of Retinal
Vascular Diameter Changes?
We thank Kotliar and Lanzl for their interesting thoughts,
which we believe contribute to the development of the best
scientific analysis of ocular blood vessels in response to dis-
ease. This topic is rapidly developing and has clear indications
for other diseases, such as diabetes. Nevertheless, we would
like to take the opportunity to respond to the points raised by
our colleagues.
In their opening paragraph, they suggest that our charac-
terization of vessel elasticity is flawed by the nature of the
assessment. They contend (1) that vessel elasticity cannot be
characterized by a single assessment of reactive vessel dilation
in response to flicker light and a determination of the magni-
tude of spontaneous vascular vasomotions. We are puzzled by
this point, as a major premise of our new method is that a
single assessment alone is insufficient because of the baseline
diameter fluctuation (BDF) of the vessel. We analyzed flicker
response three times to ensure a greater confidence in our
data. In the final paragraph of the Results section, we present
data that show no difference (P  0.343) in APR taken at three
time points.1 In addition, (2) they suggest that we do not
explain the reason for calling APR a measure of elasticity and
that the results of the APR are not disclosed anywhere in the
paper. We call APR a measure of elasticity because it accounts
for the increase in vessel diameter, which then returns to
baseline. This we showed with the relationship between max-
imum vasomotion under resting conditions and under stimula-
tory (e.g., flicker) conditions. In their final sentence, they say
that the results of the APR are not disclosed in our paper. The
data are indeed presented at end of the Results section.
In their second paragraph, our colleagues question the
index that we have named D, which represents the degree of
vessel dilation that occurs between the time point of flicker
initiation and maximum vascular dilation. They suggest that the
problem inherent in this new parameter is its arbitrary limita-
tion to a 1-second diameter assessment before flicker initiation
as its main reference point. First, we would like to further
explain why we believe a 1-second mean diameter is a suitable
measure. The human heart beats at intervals of roughly one
second, which is also visible in most RVA recordings (Fig. 1),
and therefore an average of the 25 diameter recordings before
flicker initiation, which are sampled in 1 second, appears to be
a suitable means of reflecting the vessel size directly before the
stimulation cycle. We explained that there is a limit to how
much any vessel can dilate (in the Methods section on SDRA
and in the Results section, paragraph five1). In addition, our
colleagues state that reduced vessel dilation during the second
and third flicker episodes in our healthy patients differed from
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those in the smoking sample for D. We want to emphasize
that we showed correlations only between the 1-second mean
baseline diameter and the D in healthy subjects and did not
compare or show the correlations for the smoking sample. Our
comparison between groups is solely for the parameters
shown in Tables 4, 5, and 6 of our paper. In the figure showing
two individuals assessed by Kotliar and Lanzl, they present two
arterial plots to justify the view that individuals differ signifi-
cantly in flicker pattern during each cycle. While these data are
interesting, we do not share their view, because the data for
only 21 nonsmokers in our Table 4 in the original paper show
that the individual parameters (BDF, DA [diameter amplitude],
and BFG) for each of three flicker cycles are no different in
arteries and veins. To further underline this, we present, with
considerably greater power, new supporting data from 78
healthy individuals (Table 1), unequivocally demonstrating that
there is no change in response to three cycles of flicker.
In paragraph three, Kotliar and Lanzl suggest a possible
source of error in our calculations. First, there seems to be a
basic misunderstanding: All parameters (BDF, MD [maximum
dilation], MC [maximum constriction], DA, and time re-
sponses) were not set in any relation or based on or calculated
to D, contrary to their statement. BDF is the relative baseline
diameter fluctuation, MD is the relative maximum dilation due
to flicker, and so on and has been calculated from the raw data
individually for each flicker episode.
Paragraph four has several issues. Kotliar and Lanzl further
question the relevance of using three stimulation cycles, high-
lighting that, in their measurements, healthy individuals re-
spond differently in each cycle and also that sometimes not all
cycles are recorded, and so the average response should be
taken. Correctly, this tripling of the number of analyzed pa-
rameters can reduce the level of statistical significance. This
may be correct, but our analysis of the data that we presented
in Table 4 (and elsewhere) is according to repeated-measures
analysis of variance (Friedman’s two-way method), which ad-
justs for individual variances and so is a particularly powerful
method.2 Second, our colleagues cite the paper by Kvernmo et
al.3 to explain their different hypothesis on retinal vasomotion;
however, although informative in a general setting, we cannot
see the relevance of this paper to our study, since Kvernmo et
al. used a laser Doppler technique to examine the cutaneous
blood flow of capillaries, arterioles, venules, and dermal vas-
cular plexi, rather than single vessel motion. Third, Kotliar and
Lanzl state that, in their example, the two individuals would
show significant dilatory results if our analysis paradigm were
used and raise the question of which flicker should be used for
analysis. In addition, they question whether the difference
detected between smokers and nonsmokers is unique and
manifests in a similar way in other diseases, and they mention
that healthy volunteers may demonstrate differing results de-
spite their similar pathophysiologic status. In regard to the
question of which flicker should be used, we stress that, if a
repeated-measures protocol is used, all measures should be
taken into account and that, if a data recording is incomplete,
it should be excluded from further analysis. The advantage of
a repeated procedure lies not only in increasing confidence but
also in enabling a reaction pattern and examining any “exhaus-
tive” effect. Any measurement taken from two individuals will
have differences; these do not generally relate to disease but
are part of a “normal range” within a chosen sample. For this
reason, we measured a large number of people, to examine the
range and dependencies of our proposed marker.
In their fifth paragraph, Kotliar and Lanzl state that a qual-
itative assessment of each single flicker episode is not always
possible in all subjects (elderly population, subjects with bad
fixation, and those with excessive blinking during the assess-
ment), which represents a serious limitation in our novel
method. We are aware that it can be difficult, in some patients,
to obtain all three cycles; however, in our study we analyzed
only the data sets in which all three cycles were completely
recorded. Assessments of individuals with poor fixation or
excessive blinking should be removed if all cycles were not
recorded (especially when evaluating normative parameters,
good fixation is essential), since eye movements can introduce
a significant error especially in regard to diameter fluctuations
attributable to vasomotion. The conclusion that fixation, eye
movements, and incomplete recordings can influence the re-
sult is therefore correct but does not apply to our data set,
since we included only subjects with good fixation and in
whom all three cycles were completely recorded.
FIGURE 1. A trace of a 2-second base-
line diameter recording of a retinal
arteriole and venule in a healthy 40-
year-old individual, obtained with the
retinal vessel analyzer (IMEDOS Sys-
tems UG, Jena, Germany).
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Main Criticism
In the first point of their summary, our colleagues state that it
is necessary to assess the maximum dilation at the time point
of its occurrence rather than at the fixed time point of flicker
cessation, as we proposed in our paper, and they refer to two
publications4,5 stating that this problem had been addressed
before our publication. To clarify this matter, our publication
had been submitted before the publication date of one of these
studies5; furthermore, both referenced studies involved only
10 healthy subjects, and despite evaluating individual time
responses, some dilatory parameters were averaged over three
flicker cycles, or averaged diameter values of up to 4 seconds
were used. We also want to stress that these papers examined
pathologic changes rather than analysis validity, as there was a
maximum of 11 healthy volunteers who were matched to the
pathologic group, and a cross-sectional view of all ages was
therefore lacking. We presented data of 78 healthy individuals
with an age range of 17 to 70 years.
In point two of Kotliar and Lanzl’s main criticism they
state that we reported “a possible higher rate of dilation in
the first flicker episode in the group of healthy subjects,
compared with subsequent episodes, and in the first flicker
episode in smokers.” Again, we refer to Table 4 in our paper
for clarification. It clearly shows a similar dilatory response
at baseline and during provocation for each flicker cycle in
the 21 healthy controls but not in the smokers. We included
the data for all 78 healthy subjects in Table 1 herein, which
are similar to those of the 21 subjects randomly chosen to
match the smoking group.
Summary
A protocol with repeated stimulation cycles should be ana-
lyzed stepwise, in that each stimulation is evaluated, and a
reaction pattern is identified. No two subjects will react
identically, in that dilation and recovery times can vary;
however, this is not reason enough to abandon a multiple
stimulation cycle with fixed recovery and stimulation times.
Furthermore, it enables us to examine and determine the
range in which a normal subject will be placed and can then
be compared to different pathophysiological states (i.e.,
smokers and different diseases). The purpose of our paper
was to highlight the importance of evaluating these different
cycles and the danger of false interpretation when averaging
results. There are many different ways of evaluating dilatory
responses and elasticity, but each of them must be carefully
evaluated and should not be overaveraged, which can result
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TABLE 1. Retinal Arterial and Venous Dilatory Parameters in








Flicker 1 4.04 (2.13) 0.654
Flicker 2 4.16 (2.13)
Flicker 3 4.31 (2.59)
MD
Flicker 1 4.64 (2.69) 0.432
Flicker 2 4.81 (2.69)
Flicker 3 5.04 (2.66)
DA
Flicker 1 7.94 (3.56) 0.581
Flicker 2 8.02 (3.26)
Flicker 3 8.33 (3.50)
BFR
Flicker 1 3.75 (2.63) 0.174
Flicker 2 3.85 (2.68)
Flicker 3 4.01 (2.78)
Venous Response
MD
Flicker 1 5.80 (2.63) 0.750
Flicker 2 5.81 (2.29)
Flicker 3 6.08 (2.45)
MC
Flicker 1 1.27 (1.34) 0.697
Flicker 2 1.28 (1.33)
Flicker 3 1.23 (1.31)
DA
Flicker 1 7.08 (3.17) 0.171
Flicker 2 7.09 (2.86)
Flicker 3 7.30 (3.02)
Data are expressed as the mean (SD). All relative values are
expressed as the percentage of change in relation to baseline diameter.
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